Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative RARE - Ultragenyx Pharmaceutical Inc.
310 M
LAST VALUE
18.67%
2 YEAR CAGR
19.39%
5 YEAR CAGR
52.85%
10 YEAR CAGR